About SES-CAB
SES-CAB: Science, Evidence & Safety Clinical Advisory Board is a United States–based, evidence-driven resource for clear, trustworthy information on pharmaceuticals, diseases, and supplements. We bring together clinical expertise and rigorous research methods to help patients, caregivers, and professionals make safer, more informed decisions.
Our content focuses on safety, efficacy, dosing, drug interactions, side effects, and treatment options—summarized in accessible language and grounded in current scientific research and best-practice guidelines.
Our Mission
Our mission is to improve health outcomes by delivering reliable, up-to-date, and actionable guidance on medications and therapies. We prioritize patient safety and clarity, while maintaining a high standard of scientific integrity and transparency.
What We Offer
Drug Information
Concise, evidence-based profiles that summarize indications, dosing ranges, contraindications, side effects, monitoring parameters, and special population considerations.
Disease Guides
Condition overviews that cover symptoms, diagnosis, treatment options, lifestyle considerations, and shared decision-making tips—aligned with current guidelines and clinical best practices.
Supplements and Integrative Therapies
Balanced reviews of vitamins, minerals, and herbal products, including potential benefits, known risks, quality concerns, and interactions with prescription therapies.
Safety Tools and Interactions
Practical summaries on drug–drug, drug–disease, and drug–supplement interactions, as well as adverse effect profiles and risk mitigation strategies.
How We Ensure Quality
Evidence Gathering
- We prioritize high-quality sources such as randomized trials, systematic reviews, meta-analyses, and established clinical guidelines.
- When high-level evidence is limited, we transparently explain uncertainties and rely on consensus statements and expert opinion with clear labeling.
- We evaluate study design, outcomes, bias, applicability, and safety signals before drawing conclusions.
Review and Update Cycle
- Every article undergoes editorial review and clinical fact-checking prior to publication.
- Content is reviewed on a scheduled cycle and when new safety alerts, approvals, or landmark studies are released.
- Revision histories and update rationales are documented internally to track changes and ensure accountability.
Editorial Independence and Conflicts of Interest
- Our content is developed independently of advertisers and sponsors.
- Contributors disclose potential conflicts of interest, which are reviewed as part of our governance process.
- Safety and patient welfare take precedence over commercial considerations.
Accessible for Patients, Useful for Professionals
- Plain-language summaries for patients and caregivers to support informed discussions with clinicians.
- Clinically oriented details for healthcare professionals, including dosing considerations, monitoring, and interactions.
Clinical Advisory Board
Role and Responsibilities
The Clinical Advisory Board provides expert guidance on clinical accuracy, safety priorities, and methodological rigor. Board advisors review high-impact topics, inform our editorial standards, and help interpret emerging evidence.
Areas of Expertise
Our advisory expertise spans internal medicine, pharmacology, nursing, pharmacy practice, and related specialties to reflect the multidisciplinary nature of safe medication use.
Governance
The Board operates under a governance framework that emphasizes transparency, conflict-of-interest management, and a clear separation between editorial decisions and any external influence.
For Patients and Caregivers
We aim to make complex information understandable and usable. Our guides highlight what to ask your healthcare provider, warning signs that warrant medical attention, and strategies to reduce medication-related risks.
For Clinicians and Researchers
We synthesize evidence to support point-of-care decisions, shared decision-making, and patient education. Content includes practical considerations such as dose adjustments, monitoring parameters, and interaction risks.
Ethics, Safety, and Equity
Safety First
We foreground safety signals and risk–benefit considerations, ensuring that potential harms are clearly described alongside potential benefits.
Inclusion and Accessibility
Content is designed to be accessible and inclusive, considering language clarity, health literacy, and the needs of diverse populations and care settings.
Privacy and Data Use
We respect user privacy and strive to apply minimal, necessary data practices aligned with ethical standards.
Ownership and Contact
SES-CAB is owned by Cheryl Moran.
- Owner: Cheryl Moran
- Address: 2901 Los Feliz Blvd, Los Angeles, CA 90039, United States
- Email: [email protected]
We welcome inquiries about our methodology, content policies, and opportunities for collaboration.
Disclaimers and Appropriate Use
- Information provided by SES-CAB is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
- Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions regarding a medical condition or medication.
- If you are experiencing a medical emergency, call your local emergency number immediately.
Feedback, Corrections, and Continuous Improvement
Your feedback helps us improve accuracy and clarity. If you spot an error, an omission, or a needed update, please contact us. We evaluate all suggestions using our editorial and clinical review process and update content accordingly.
Our Commitment
SES-CAB is committed to clarity, safety, and scientific integrity. We strive to be a trusted partner for patients and professionals by maintaining a rigorous, transparent process and keeping pace with evolving evidence and best practices.